From the editor

Article

Happy New Year to you all and welcome to the second edition of Ophthalmology Times Europe.

This issue sees us ask the question "Will phakic IOL implantation become the procedure of choice for certain forms of refractive correction?" Some experts believe so and this month we are fortunate enough to relay to you the opinions, knowledge and experience of several refractive specialists. With each tackling various issues relating to phakic IOL use, is the evidence presented here compelling enough for you to tout the new generation of refractive lenses as a force to be reckoned with? Could you convince your patients to accept this form of refractive correction, despite current perceptions? Read on and form your own opinions.

Elsewhere, we focus on advances in the ever-changing area of corneal surgery. Massimo Busin describes a new method of microkeratome-assisted penetrating keratoplasty that does not require endothelial transplantation for advanced keratoconus - a study that gained him an award for a "Best National Paper on Ophthalmology" from the World Ophthalmology Congress 2006. Meanwhile, Daljit Singh describes a new method, which could eliminate the need for corneal transplants in certain cases. Also in this issue, we present some recent advances and cutting edge discoveries in the areas of cataract surgery and glaucoma treatment, designed to intrigue and enthuse you.

As always, I would be delighted to hear what you have to say so please do let me know what you think of Ophthalmology Times Europe, what you like, what you don't like and, most importantly, how we can serve you better. Why not stop by at the World Ophthalmology Congress in SãPaulo and speak with us personally. Alternatively, please direct any feedback to fpavlou@advanstar.com

I look forward to hearing from you.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.